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Peculiar brownish eruption and superﬁcial lymphadenopathy in a middle-aged
manCase report
A 49-year-old Taiwanese male developed many discrete irregularly
shaped brownish macules and patches (diameter 0.3–4.0 cm) that
had disseminated over his entire body, predominantly on the
head and back; these macules and patches persisted for 8 months
(Figures 1A and 1B). The lesions had begun on his face and had
gradually spread to his trunk and extremities. A computed tomog-
raphy scan revealed multiple palpable and non-tender lymph
nodes in the occipital, periauricular and submandibular regions
and in the neck. A systemic physical examination revealed that
he was healthy, that he had not lost body weight, and that he
was without constitutional discomfort and systemic disease. The
histopathologic ﬁndings of trunk skin biopsy showed acanthosis
with elongation of epidermal rete ridges, basal hyperpigmenta-
tion, and moderate perivascular inﬁltration of predominantly
mature plasma cells with a few lymphocytes and histiocytes in
the dermis (Figure 2). The immunohistochemical staining
revealed that these plasma cells were positive for both kappa
and lambda light chains. The pathologic features of the lymph
node of the neck revealed reactive follicular hyperplasia with
many mature plasma cells in the interfollicular area (Figures 3A
and 3B).Figure 1 Diffuse discrete irregularly shaped brownish macules and patches, 0.3–4 cm, on the f
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doi:10.1016/j.dsi.2011.09.019Laboratory examination yielded the following remarkable ﬁnd-
ings: elevated serum total protein concentration (9 g/dL; normal:
6.4–8.4 g/dL), low albumin level (3.6 g/dL; normal: 3.7–5.3 g/dL),
and elevated levels of serum immunoglobulins (Igs) G and A [IgG,
3550 mg/dL (normal: 751–1560 mg/dl); IgA, 675 mg/dL (normal:
82–453 mg/dL); and normal IgM level. The patient had mild leuko-
cytosis, elevated erythrocyte sedimentation rate, C-reactive protein
level, and lactate dehydrogenase level. Serum protein electropho-
resis showed reversed albumin/globulin ratio (A/G: 0.4) and poly-
clonal gammopathy. Elevated levels of serum kappa (3000 mg/dL;
normal: 542–1248 mg/dL) and lambda light chain (1300 mg/dL;
normal: 293–725 mg/dL) and absence of monoclonal Ig light chains
were observed. Complete blood cell counts revealed absence of
anemia, and the biochemistry panel showed normal ﬁndings. A
trace amount of proteinwas detected in the urine. Serologic surveys
revealed an absence of possible disease with cutaneous predomi-
nant plasma cell inﬁltration, including autoimmune connective
tissue diseases (ANA, anti-ds DNA). Moreover, chronic infections
such as syphilis and infections with human immunodeﬁciency
virus, hepatitis B virus, hepatitis C virus, Epstein-Barr virus, and
Borrelia (Lyme disease) were absent. Plain radiography of the chest,
skull, and long bones revealed absence of osteolytic lesions. Ultra-
sonography revealed that hepatosplenomegaly was absent.ace, neck (A) and back (B). Note the palpable lymphadenopathy on the neck (arrow in A).
. Published by Elsevier Taiwan LLC. All rights reserved.
Figure 2 (A) Dense dermal perivascular and periadnexal inﬁltration of plasma cells
(hematoxylin and eosin stain, original magniﬁcation, 40). (B) Higher magniﬁcation
revealed numerous plasma cells mixed with lymphocytes and histiocytes without aty-
pia (hematoxylin and eosin stain, original magniﬁcation, 400). (C) Positive stain with
kappa light chain (400). (D) Positive stain with lamda light chain (400).
Figure 3 The pathologic features of enlarged lymph node on neck. (A) reactive follic-
ular hyperplasia with preserved nodal architecture (hematoxylin and eosin stain, orig-
inal magniﬁcation, 40). (B) Many mature plasma cells and lymphocytes in the
interfollicular area (hematoxyline and eosin stain, original magniﬁcation, 400).
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Cutaneous plasmacytosis (CP).
Discussion
CP is a rare entity and is characterized by a clinical triad of distinc-
tive cutaneous lesions, superﬁcial lymphadenopathy and polyclonal
hypergammaglobulinemia. Other organs are not involved.1–3 The
typical skin lesions are brownish irregularly shaped macules,
patches or plaques, which are mostly disseminated on the trunk.Histopathological analysis revealed dense perivascular and periad-
nexal inﬁltrates of predominant mature plasma cells with a few
lymphocytes and histiocytes in the dermis. Immunohistochemical
analysis revealed that the plasma cells are polyclonal, as indicated
by the positive staining of both kappa and lambda chains.1–3
Cutaneous plasma cell inﬁltration may be observed in a variety
of disorders such as connective tissue disorder, plasma cell
neoplasm and chronic infections, including syphilis and Lyme
disease, but the cutaneous manifestations in these disorders are
different from those in CP.
CP usually follows a chronic and benign course without sponta-
neous resolution and is refractory to various treatments. Most of
these patients had no detectable underlying diseases.
Systemic plasmacytosis (SP) was ﬁrst proposed by Watanabe
et al in 1986.1 Cases with SP had more than two organs involved,
including skin and lymph nodes. Most authors agree that SP should
not be diagnosed in patients if only the skin and lymph nodes are
involved. A few reported patients had systemic involvement2,3
such as fever, dyspnea, malaise, weight loss, anemia and hepatosple-
nomegaly. Some had benign conditions initially, which become
aggressive years later as lymphoid interstitial pneumonia, squamous
cell carcinoma of the anal region and the lung, or T-cell lymphoma.
The treatments for CP have variable efﬁcacy. Topical or intrale-
sional injection of corticosteroids, topical tacrolimus, or adminis-
tration of topical photochemotherapy (PUVA),4,5 photodynamic
therapy,4 lead to partial remission in cases with focal lesions; while
systemic corticosteroids as well as systemic chemotherapy are
useful for cases with systemic involvement.1–3
In conclusion, our patient had a typical clinical triad of CP with
mature plasma cell inﬁltrates in the skin and lymph nodes. He was
asymptomatic without any other systemic involvement. No
evidences of infection or connective tissue disease were noted.
Plasma cell neoplasm could be excluded because of absence of
cell atypia and monoclonal cells in the skin and blood. He under-
went a few sessions of psoralenþUVA (PUVA) therapy, but did
not show a remarkable improvement. As per the patient’s request,
no further treatment planwas arranged. At the 6-month follow-up,
the skin lesions and lymph node inﬂammation were found to be
persistent without any other systemic involvement.
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